Comparison between Genpharmasec Rights Issue 2024 and Lloyds Engineering Works Rights Issue 2023.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Genpharmasec Rights Issue 2024 and Lloyds Engineering Works Rights Issue 2023. Genpharmasec Rights Issue 2024 is listed on BSE while Lloyds Engineering Works Rights Issue 2023 is listed on BSE, NSE.
| Genpharmasec Limited | Lloyds Engineering Works Limited | |
|---|---|---|
| Logo |  |  |
| Listing At | BSE | BSE, NSE |
| Terms of Payment | Full amount of Rs.1.75 per Equity Share is payable on application. | The entire amount of the Issue Price of ₹ 15.50 per Rights Equity Share shall be payable at the time of Application. |
| Entitlement | 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 17 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  | Application Form |
| Letter of Offer | Letter of Offer | Letter of Offer |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Lead Managers | Pioneer Investcorp Ltd. Mark Corporate Advisors Pvt.Ltd. |
The issue size of Genpharmasec Rights Issue 2024 rights issue is ₹48.45 Crores, whereas Lloyds Engineering Works Rights Issue 2023 rights issue size is ₹98.37 Crores.
| Genpharmasec Limited | Lloyds Engineering Works Limited | |
|---|---|---|
| Issue Size | 27,68,59,850 shares | 6,34,64,610 shares |
| Issue Size (Amount) | ₹48.45 Crores | ₹98.37 Crores |
| Issue Price | ₹1.75 per share | ₹15.5 per share |
| Face Value | ₹1 per share | ₹1 per share |
Find all the important dates related to the rights issue. The record date of Genpharmasec Rights Issue 2024 is Jan 09, 2024 while record date of Lloyds Engineering Works Rights Issue 2023 is Dec 14, 2023.
| Genpharmasec Limited | Lloyds Engineering Works Limited | |
|---|---|---|
| Record Date | Jan 09, 2024 | Dec 14, 2023 |
| Credit of Rights Entitlements | Jan 21, 2024 | |
| Bid/Offer Opens On | Jan 23, 2024 | Dec 26, 2023 |
| Renunciation of Rights Entitlements | Feb 02, 2024 | Jan 05, 2024 |
| Bid/Offer Closes On | Feb 13, 2024 | Jan 10, 2024 |
| Deemed Date of Allotment | Feb 16, 2024 | Jan 18, 2024 |
| Credit Date | Feb 21, 2024 | Jan 19, 2024 |
| Listing Date | Feb 26, 2024 | Jan 24, 2024 |
Comparison of Genpharmasec Rights Issue 2024 and Lloyds Engineering Works Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Genpharmasec Limited | Lloyds Engineering Works Limited | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Genpharmasec Limited Financial Information (Restated)Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.
| Lloyds Engineering Works Limited Financial Information (Restated)Lloyds Engineering Works Limited's revenue increased by 432.03% and profit after tax (PAT) rose by 519.17% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
